Efficacy and Adverse Events Associated With Use of OnabotulinumtoxinA for Treatment of Neurogenic Detrusor Overactivity: A Meta-Analysis

  

Outcomes of sequential third‐line therapies in patients with refractory overactive bladder

Po‐Ming Chow, Tyler Trump, Howard B. Goldman

International Journal of Urology.2024; 31(7): 772.     CrossRef

Influence of regulatory peptides on neurogenic lower urinary tract dysfunction in multiple sclerosis. Data of one center

Nemer N.M. Abdallah, I. I. Belousov, Z. A. Goncharova, O. Yu. Rudenko, M. E. Belousova

South Russian Journal of Therapeutic Practice.2024; 5(2): 79.     CrossRef

Intravesikale Behandlungsoptionen in der Neuro-Urologie – eine Übersicht

Anke K. Jaekel, Stephanie C. Knüpfer, Ruth Kirschner-Hermanns

Aktuelle Urologie.2024; 55(04): 344.     CrossRef

An overview on disease modifying and symptomatic drug treatments for multiple sclerosis

Gloria Dalla Costa, Letizia Leocani, Mariaemma Rodegher, Luca Chiveri, Alessandro Gradassi, Giancarlo Comi

Expert Review of Clinical Pharmacology.2024; 17(10): 901.     CrossRef

Long‐term follow‐up of intradetrusor botulinum toxin utilisation: A comparison of patients with multiple sclerosis and idiopathic overactive bladder

William Chui, Joshua Kealey, Henry H. Yao, Garson Chan, Alvaro Bazo, Richard Parkinson, Helen E. O'Connell, Johan Gani

BJUI Compass.2024;[Epub]     CrossRef

Stem Cell Therapy in Spinal Cord Injury-Induced Neurogenic Lower Urinary Tract Dysfunction

Yin-Chien Ou, Chi-Chen Huang, Yao-Lin Kao, Pei-Chuan Ho, Kuen-Jer Tsai

Stem Cell Reviews and Reports.2023; 19(6): 1691.     CrossRef

Quality of Life in Female Patients with Overactive Bladder after Botulinum Toxin Treatment

Agnieszka A. Licow-Kamińska, Sylwester M. Ciećwież, Magdalena Ptak, Dariusz Kotlęga, Agnieszka Brodowska

Toxins.2023; 16(1): 7.     CrossRef

Video-Urodynamic Characteristics and Predictors of Switching from Botulinum Neurotoxin a Injection to Augmentation Enterocystoplasty in Spinal Cord Injury Patients

Chih-Chieh Lin, Hann-Chorng Kuo

Toxins.2022; 14(1): 47.     CrossRef

Neurogenic bladder – concepts and treatment recommendations

José Carlos Truzzi, Fernando Gonçalves de Almeida, Carlos Alberto Sacomani, Joceara Reis, Flávio Eduardo Trigo Rocha

International braz j urol.2022; 48(2): 220.     CrossRef

Neurogenic Bladder Physiology, Pathogenesis, and Management after Spinal Cord Injury

Nathalie Elisabeth Perez, Neha Pradyumna Godbole, Katherine Amin, Raveen Syan, David R. Gater

Journal of Personalized Medicine.2022; 12(6): 968.     CrossRef

Trigonal-Sparing vs. Trigonal-Involved OnabotulinumtoxinA Injection for the Treatment of Overactive Bladder: A Systematic Review and Meta-Analysis

Yuanshan Cui, Tong Cai, Tiantian Dong, Xiaoyi Zhang, Zhongbao Zhou, Youyi Lu, Yong Zhang, Jitao Wu, Zhenli Gao, Yongqiang Wang, Liying Dong

Frontiers in Neurology.2021;[Epub]     CrossRef

Guideline for the management of pre-, intra-, and postpartum care of women with a spinal cord injury

Sue Bertschy, Markus Schmidt, Kai Fiebag, Ute Lange, Simone Kues, Ines Kurze

Spinal Cord.2020; 58(4): 449.     CrossRef